Changes of Plasma Adiponectin Levels After Smoking Cessation

Overview

Journal Psychiatry Investig

Specialty Psychiatry

Date 2014 May 21

PMID 24843373

Citations 9

Authors

Wang-Youn Won

Chang-Uk Lee

Jeong-Ho Chae

Jung-Jin Kim

Chul Lee

Dai-Jin Kim

Affiliations

Soon will be listed here.

Abstract

Objective: Cigarette smoking is associated with a variety of health problems including cardiovascular, pulmonary, neoplasms, endocrinopathies including diabetes, the metabolic syndrome, and chronic inflammation. Adiponectin is an adipocyte-derived plasma protein that is closely associated with insulin sensitivity and the metabolic syndrome. The aim of this study was to evaluate the changes of plasma adiponectin levels after smoking cessation.

Methods: Thirty seven smokers that wanted to stop smoking without any nicotine replacement therapy or medication were recruited for this study. Fifteen smokers succeeded in stopping smoking (validated by urine cotinine levels ≤50 ng/mL) and 22 smokers failed. Therefore, only the 15 that succeeded were included in the analysis. The plasma adiponectin levels were determined using a commercially available enzyme-linked immunosorbent assay.

Results: The mean age of the successful 15 was 35±9.3 years old. They were all males. The daily smoking habit was a mean of 13.5±5.4 cigarettes per day. The mean Nicotine Dependence Syndrome Scale (NDSS) and Fagerstrom Test for Nicotine Dependence (FTND) scores were 55.6±9.6 and 2.9±1.9. During the study period of three months, the mean body mass index (BMI), body fat mass (BFM), waist-hip ratio (WHR) and body weight increased by 1.1 kg/m(2), 3.0%, 0.02%, and 2.9 kg, respectively. The baseline mean adiponectin level in the subjects was 11.9±5.2 mg/L. The mean adiponectin levels measured at one and three months were 16.0±5.1 mg/L and 14.7±4.5 mg/L respectively. The mean plasma adiponectin levels of the successful group was significantly increased after four weeks when compared to the baseline (z=-2.401, p=0.016). However, the decrease in plasma adiponectin levels at one and three months was not statistically significant.

Conclusion: Even though the decrease over the next two months was not significant, these findings, the increase of plasma level of adiponectin after smoking cessation, provide preliminary data for future research on the possible mechanisms associated with smoking cessation and changes in body metabolism.

Citing Articles

The Effect of Smoking Cessation on Body Weight and Other Metabolic Parameters with Focus on People with Type 2 Diabetes Mellitus.

Driva S, Korkontzelou A, Tonstad S, Tentolouris N, Katsaounou P Int J Environ Res Public Health. 2022; 19(20).

PMID: 36293800 PMC: 9603007. DOI: 10.3390/ijerph192013222.

Smoking results in accumulation of ectopic fat in the liver.

Kato A, Li Y, Ota A, Naito H, Yamada H, Nihashi T Diabetes Metab Syndr Obes. 2019; 12:1075-1080.

PMID: 31372017 PMC: 6628959. DOI: 10.2147/DMSO.S212495.

Evaluation of the distribution of nicotine intravenous injection: an adult autopsy case report with a review of literature.

Aoki Y, Ikeda T, Tani N, Shida A, Oritani S, Ishikawa T Int J Legal Med. 2019; 134(1):243-249.

PMID: 30955048 PMC: 6949309. DOI: 10.1007/s00414-019-02035-y.

Effects of nicotine on homeostatic and hedonic components of food intake.

Stojakovic A, Espinosa E, Farhad O, Lutfy K J Endocrinol. 2017; 235(1):R13-R31.

PMID: 28814527 PMC: 5578410. DOI: 10.1530/JOE-17-0166.

Adiponectin Potentially Contributes to the Antidepressive Effects of Baduanjin Qigong Exercise in Women With Chronic Fatigue Syndrome-Like Illness.

Chan J, Li A, Ng S, Ho R, Xu A, Yao T Cell Transplant. 2016; 26(3):493-501.

PMID: 27938498 PMC: 5657703. DOI: 10.3727/096368916X694238.

References

Bamia C, Trichopoulou A, Lenas D, Trichopoulos D . Tobacco smoking in relation to body fat mass and distribution in a general population sample. Int J Obes Relat Metab Disord. 2004; 28(8):1091-6. DOI: 10.1038/sj.ijo.0802697. View

Ferrara C, Kumar M, Nicklas B, McCrone S, Goldberg A . Weight gain and adipose tissue metabolism after smoking cessation in women. Int J Obes Relat Metab Disord. 2001; 25(9):1322-6. DOI: 10.1038/sj.ijo.0801716. View

Staiger H, Tschritter O, Machann J, Thamer C, Fritsche A, Maerker E . Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans. Obes Res. 2003; 11(3):368-72. DOI: 10.1038/oby.2003.48. View

Havel P . Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr Opin Lipidol. 2002; 13(1):51-9. DOI: 10.1097/00041433-200202000-00008. View

Iwashima Y, Katsuya T, Ishikawa K, Kida I, Ohishi M, Horio T . Association of hypoadiponectinemia with smoking habit in men. Hypertension. 2005; 45(6):1094-100. DOI: 10.1161/01.HYP.0000169444.05588.4c. View

Dallosso H, James W . The role of smoking in the regulation of energy balance. Int J Obes. 1984; 8(4):365-75. View

Kubota N, Yano W, Kubota T, Yamauchi T, Itoh S, Kumagai H . Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab. 2007; 6(1):55-68. DOI: 10.1016/j.cmet.2007.06.003. View

Heatherton T, Kozlowski L, Frecker R, Fagerstrom K . The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991; 86(9):1119-27. DOI: 10.1111/j.1360-0443.1991.tb01879.x. View

Moffatt R, Owens S . Cessation from cigarette smoking: changes in body weight, body composition, resting metabolism, and energy consumption. Metabolism. 1991; 40(5):465-70. DOI: 10.1016/0026-0495(91)90225-l. View

10.

Filozof C, Fernandez Pinilla M, Fernandez-Cruz A . Smoking cessation and weight gain. Obes Rev. 2004; 5(2):95-103. DOI: 10.1111/j.1467-789X.2004.00131.x. View

11.

Lee H, Joe K, Kim W, Park J, Lee D, Sung K . Increased leptin and decreased ghrelin level after smoking cessation. Neurosci Lett. 2006; 409(1):47-51. DOI: 10.1016/j.neulet.2006.09.013. View

12.

Canoy D, Wareham N, Luben R, Welch A, Bingham S, Day N . Cigarette smoking and fat distribution in 21,828 British men and women: a population-based study. Obes Res. 2005; 13(8):1466-75. DOI: 10.1038/oby.2005.177. View

13.

Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N . Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol. 2003; 23(1):85-9. DOI: 10.1161/01.atv.0000048856.22331.50. View

14.

Harvey J . Leptin regulation of neuronal excitability and cognitive function. Curr Opin Pharmacol. 2007; 7(6):643-7. PMC: 2635528. DOI: 10.1016/j.coph.2007.10.006. View

15.

Takefuji S, Yatsuya H, Tamakoshi K, Otsuka R, Wada K, Matsushita K . Smoking status and adiponectin in healthy Japanese men and women. Prev Med. 2007; 45(6):471-5. DOI: 10.1016/j.ypmed.2007.07.001. View

16.

Abbasi F, Farin H, Lamendola C, McLaughlin T, Schwartz E, Reaven G . The relationship between plasma adiponectin concentration and insulin resistance is altered in smokers. J Clin Endocrinol Metab. 2006; 91(12):5002-7. DOI: 10.1210/jc.2006-0419. View

17.

Thamer C, Stefan N, Stumvoll M, Haring H, Fritsche A . Reduced adiponectin serum levels in smokers. Atherosclerosis. 2005; 179(2):421-2. DOI: 10.1016/j.atherosclerosis.2004.12.039. View

18.

Pischon T, Girman C, Hotamisligil G, Rifai N, Hu F, Rimm E . Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004; 291(14):1730-7. DOI: 10.1001/jama.291.14.1730. View

19.

Patel J, Abraheem A, Dotsenko O, Creamer J, Gunning M, Hughes E . Circulating serum adiponectin levels in patients with coronary artery disease: relationship to atherosclerotic burden and cardiac function. J Intern Med. 2008; 264(6):593-8. DOI: 10.1111/j.1365-2796.2008.02007.x. View

20.

van der Lely A, Tschop M, Heiman M, Ghigo E . Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev. 2004; 25(3):426-57. DOI: 10.1210/er.2002-0029. View